Donald L. Hagan, LLC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 82 filers reported holding ANTARES PHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Donald L. Hagan, LLC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2016$2,000
-97.3%
2,000
-95.5%
0.00%
-97.0%
Q3 2015$75,000
-18.5%
44,0000.0%0.07%
-22.1%
Q2 2015$92,000
-22.7%
44,0000.0%0.09%
-27.1%
Q1 2015$119,000
+5.3%
44,0000.0%0.12%
+12.4%
Q4 2014$113,00044,0000.10%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders